Does saw palmetto help the prostate or hair loss? For the prostate, the answer is no

Saw palmetto, an extract of the berry of a North American dwarf palm, is one of the most widely sold herbal remedies for men — marketed for an enlarged prostate and, more recently, for thinning hair. For the prostate, the verdict from the strongest trials is clear and unflattering: it does not work [s1][s2]. For hair loss, there is no scandal, just an absence of good evidence — the claim rests on a scatter of small, low-quality studies [s3].

The prostate claim, tested properly

The idea is biologically tidy. Saw palmetto is thought to block the enzyme that converts testosterone to its more potent form, the same target as the prescription drug finasteride, so it ought to ease the urinary symptoms of benign prostatic hyperplasia — the weak stream, the urgency, the getting up at night. The definitive test was the CAMUS trial, a rigorous double-blind study in which 369 men aged 45 or older were given saw palmetto extract or placebo and, crucially, the dose was pushed to one, two and then three times the standard 320 mg per day [s1].

Over 72 weeks, symptom scores on the American Urological Association Symptom Index fell by 2.20 points on saw palmetto and 2.99 points on placebo — a difference that not only failed to favour the herb but slightly favoured the dummy pill [s1]. Escalating the dose to triple strength changed nothing, and saw palmetto beat placebo on none of the secondary measures, including flow rate and nocturia [s1]. The one consolation: no clearly attributable side effects, so it is at least safe [s1].

CAMUS did not stand alone. A Cochrane systematic review pooling the trials reached the same conclusion: across two high-quality long-term studies, saw palmetto was no better than placebo at reducing urinary symptoms, with a mean difference of just 0.25 points on the same scale [s2]. The review assessed secondary measures including nocturia and urinary flow and again found no advantage for the herb over placebo [s2]. That symptom scores improved substantially in the placebo groups of these trials is a reminder of how easily an inert pill can look effective when men are simply asked how they feel over time. When early enthusiasm rested on small, short, poorly blinded trials and the effect vanished as the studies got bigger and more rigorous, that is the classic signature of a supplement that does not work.

The hair-loss claim, barely tested

The newer pitch — saw palmetto as a "natural finasteride" for male-pattern baldness — leans on the same enzyme logic. Here the evidence is not negative so much as thin. A systematic review of saw palmetto in alopecia found only five randomised trials and two cohort studies, and while they reported positive-sounding numbers — around 60% of users judging their hair quality improved, a 27% rise in total hair count, greater hair density in 83.3% of patients in some studies — the authors were blunt about the caveats [s3].

Those studies were small, often combined saw palmetto with other ingredients so its individual contribution could not be isolated, and used varying doses and formulations [s3]. The reviewers concluded that saw palmetto "may be a treatment option" for men with androgenetic alopecia but that robust, high-quality data are lacking and larger trials of saw palmetto alone are needed [s3]. That is a long way from the proof that stands behind finasteride and minoxidil, the two treatments with regulatory backing and repeated trial support.

What this means

For urinary symptoms from an enlarged prostate, the money spent on saw palmetto is money wasted on the evidence as it stands — men who are bothered should ask about alpha-blockers such as tamsulosin, or 5-alpha-reductase inhibitors such as finasteride, which have earned their place in the guidelines [s1][s2]. For hair, saw palmetto is not proven to work; a man set on trying it should know he is betting on weak data and should not expect finasteride-grade results [s3].

The wider lesson is about how supplement claims are built. Saw palmetto has a plausible mechanism, decades of use and a large market — none of which is the same as an effect. When it was finally tested at high dose against placebo, the effect was not merely small; it was absent [s1]. This is an evidence summary, not personal medical advice, but the practical takeaway is simple: for the prostate, spend the money on treatment that has been shown to work, not on a berry that has been shown not to.

Sources

• [s1] Effect of Increasing Doses of Saw Palmetto Extract on Lower Urinary Tract Symptoms: A Randomized Trial — JAMA, 2011
• [s2] Serenoa repens for benign prostatic hyperplasia — Cochrane Database of Systematic Reviews, 2012
• [s3] Natural Hair Supplement: Friend or Foe? Saw Palmetto, a Systematic Review in Alopecia — Skin Appendage Disorders, 2020